DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneSMAvoice.com | ||
If you'd like to unsubscribe and stop receiving these emails click here |
Trusted Resources: Community Center
Online groups, photo galleries and blogs
An Interview With Muscular Dystrophy Association President Donald S. Wood
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Donald S. Wood, PhD, President and CEO of the Muscular Dystrophy Association (MDA). Their conversation focuses on the latest therapies for Duchenne muscular dystrophy and spinal muscular atrophy and on the upcoming 2022 MDA Clinical & Scientific Conference.
Related Content
-
People & PlacesJohn Hopkins – Spinal Muscular Atrophy (SMA) CenterThe Spinal Muscular Atrophy (SMA) Center...
-
EducationSpinal Muscular Atrophy Type 2 (Intermediate SMA)Spinal muscular atrophy (SMA) is a genet...
-
EducationNeurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated With NusinersenObjective: To retrospectively evaluate t...
-
Community CenterInnovation in Child Neurology: Acadia’s Head of Rare Disease Shares What It Takes to Make a BreakthroughKathie Bishop, Ph.D., knows exactly what...
-
EducationCombination Therapy With Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type ISpinal muscular atrophy (SMA) is a neuro...
-
Community CenterWhy Texas Added Spinal Muscular Atrophy to Required Screenings for NewbornsKERA’s Sam Baker talks with Dr. Angela...
-
EducationNusinersen: A Review in 5q Spinal Muscular AtrophySurvival motor neuron 1 (SMN1), located ...
send a message
Reset password
password changed successfully!
please log in with your email address and new password.
your activation key expired
this confirmation key has expired. please try to log in again or resend confirmation email.
confirmation email sent
a confirmation email has been sent to your inbox. click the link in the email to activate your account.
can't find the email? be sure to check your spam folder.
password reset email sent
an email has been sent to you with a link to reset your password.
can't find the email? be sure to check your spam folder.
If you are a doctor or other qualified health care professional, you should not offer any medical advice or treatment on our Sites, nor should you allow the content of our Sites to substitute for your own medical judgment. Please thoroughly review the information provided on our Sites before deciding whether any of the products, services, or treatments therein are right for you or others.
your account is now activated!
Log in
This feature is only available to members.
you haven't confirmed your email address yet. resend confirmation email